AmpliTech Group cuts Titan Crest price to $7M, targets FY27 EBITDA
AmpliTech Group reduces Titan Crest acquisition cost to $7M while maintaining $17M backlog. Zero debt supports operations as company targets positive EBITDA in FY27 via margin improvements from scaled ORAN production.

*this image is generated using AI for illustrative purposes only.
AmpliTech Group, Inc. (NASDAQ: AMPG) has revised the economics of its asset acquisition from Titan Crest, LLC, reducing the aggregate purchase price by $1 million to $7 million. Simultaneously, the company highlighted a robust balance sheet position with zero long-term debt supporting approximately $17 million in current order backlog.
The amendment to the Asset Purchase Agreement preserves AmpliTech’s rights and claims against Titan or its affiliates arising before the change. Titan’s affiliate assumed substantially all remaining covenants and indemnification obligations under the agreement.
Financial Outlook and Margin Expansion
Management projects full-year 2026 revenue to exceed FY25 levels, though precise estimates are withheld due to timing variability in customer deployments. Certain Asian customers have shifted previously anticipated deployment schedules, affecting shipment timing but not cancelling orders. Additional shipments are expected during the second half of 2026, with a portion potentially extending into 2027.
The company outlines a path to profitability driven by margin expansion. During its initial North American MNO program, AmpliTech strategically accepted approximately $2 million in reduced profit to establish technology with a major carrier and complete commercial qualification. With this market-entry phase substantially completed, management expects future ORAN orders to carry improved economics as production scales and supply-chain efficiencies improve.
Consequently, the company currently expects to achieve positive EBITDA in Fiscal Year 2027.
What the Numbers Show
The divergence between historical margin suppression and future guidance highlights a strategic pivot from market entry to commercial scaling. The explicit acknowledgment of $2 million in accepted reduced profit during the initial phase contextualizes prior operating losses as deliberate investment rather than operational inefficiency. This aligns with the expectation that future orders will carry higher margins, suggesting that the path to positive EBITDA in 2027 is dependent on volume growth rather than cost-cutting alone.
Operational Highlights and Market Position
AmpliTech reports over $17 million in 5G ORAN-related shipments since program inception, including more than 2,000 radios shipped and in service with a Tier-1 MNO. The portfolio holds FCC and ISED Canada certifications, including a newly certified AI-ready 4T8R macro radio and small cells product line.
| Metric | Value |
|---|---|
| Titan Crest Purchase Price | $7 million |
| Current Order Backlog | $17 million |
| ORAN Shipments Since Inception | Over $17 million |
| Long-Term Debt | Zero |
| Radios Shipped/In Service | More than 2,000 |
The company is actively responding to a request for proposal from a Tier-1 telecommunications infrastructure equipment provider. Management believes this opportunity could represent tens of millions of dollars in aggregate value if awarded in full, though no assurance of award exists. Additional discussions are ongoing with mobile network operators and systems integrators in North America and international markets.
Capital is being deployed toward engineering, R&D, supply-chain capabilities, and personnel required to support larger telecommunications customers. A share repurchase authorization remains part of the capital allocation strategy, with timing subject to market conditions and liquidity.
How might the shift in deployment schedules by Asian customers impact AmpliTech's cash flow management and working capital requirements in the near term?
What specific supply-chain efficiencies or production scaling milestones must be achieved to validate the projected margin expansion for future ORAN orders?
Given the zero long-term debt position, how likely is it that AmpliTech will execute its share repurchase authorization before achieving positive EBITDA in FY2027?
































